Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
April-2023 Volume 25 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
April-2023 Volume 25 Issue 4

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Scutellarin ameliorates ischemia/reperfusion injury‑induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS‑STING pathway

  • Authors:
    • Jiu-Kang Li
    • Zhi-Ping Song
    • Xing-Zhi Hou
  • View Affiliations / Copyright

    Affiliations: Department of Infectious Diseases, The People's Hospital of Yue Chi County, Guang'an, Sichuan 638300, P.R. China, Department of Cardiovascular Medicine, The People's Hospital of Yue Chi County, Guang'an, Sichuan 638300, P.R. China
    Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 155
    |
    Published online on: February 17, 2023
       https://doi.org/10.3892/etm.2023.11854
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Ischemic heart disease is a common cardiovascular disease. Scutellarin (SCU) exhibits protective effects in ischemic cardiomyocytes; however, to the best of our knowledge, the protective mechanism of SCU remains unclear. The present study was performed to investigate the protective effect of SCU on cardiomyocytes after ischemia/reperfusion (I/R) injury and the underlying mechanism. Mice were intraperitoneally injected with SCU (20 mg/kg) for 7 days before establishing the heart I/R injury model. Cardiac function was detected using small animal echocardiography, apoptotic cells were visualized using TUNEL staining, the myocardial infarct area was assessed by 2,3,5‑triphenyltetrazolium chloride staining, and the protein levels of cyclic GMP‑AMP synthase (cGAS), stimulator of interferon genes (STING), Bcl‑2, Bax and cleaved Caspase‑3 were detected by western blotting. In in vitro experiments, H9c2 cells were pretreated with SCU, RU.521 (cGAS inhibitor) and H‑151 (STING inhibitor), before cell hypoxia/reoxygenation (H/R) injury. The viability of H9c2 cells was detected using a Cell Counting Kit‑8 assay, the rate of apoptosis was determined by flow cytometry, and the protein expression levels of cGAS, STING, Bcl‑2, Bax and cleaved Caspase‑3 were detected by western blotting. It was revealed that SCU ameliorated cardiac dysfunction and apoptosis, and inhibited the activation of the cGAS‑STING and Bcl‑2/Bax/Caspase‑3 signaling pathways in I/R‑injured mice. It was also observed that SCU significantly increased cell viability and decreased apoptosis in H/R‑induced H9c2 cells. Furthermore, H/R increased the expression levels of cGAS, STING and cleaved Caspase‑3, and decreased the ratio of Bcl‑2/Bax, which could be reversed by treatment with SCU, RU.521 and H‑151. The present study demonstrated that the cGAS‑STING signaling pathway may be involved in the regulation of the activation of the Bcl‑2/Bax/Caspase‑3 signaling pathway to mediate I/R‑induced cardiomyocyte apoptosis and cardiac dysfunction, which could be ameliorated by SCU treatment.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Wei D, Tang L, Su L, Zeng S, Telushi A, Lang X, Zhang Y, Qin M, Qiu L, Zhong C and Yu J: Edgeworthia gardneri (Wall.) Meisn. extract protects against myocardial infarction by inhibiting NF-κB-and MAPK-mediated endothelial inflammation. Front Cardiovasc Med. 9(1013013)2022.PubMed/NCBI View Article : Google Scholar

2 

Writing Committee for the VISION Study Investigators. Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, Srinathan SK, Walsh M, Abraham V, Pearse R, et al: Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 317:1642–1651. 2017.PubMed/NCBI View Article : Google Scholar

3 

Li F, Li J, Li S, Guo S and Li P: Modulatory effects of Chinese herbal medicines on energy metabolism in ischemic heart diseases. Front Pharmacol. 11(995)2020.PubMed/NCBI View Article : Google Scholar

4 

Keller K, Sagoschen I, Schmitt VH, Münzel T, Gori T and Hobohm L: Hypothermia and its role in patients with ST-segment-elevation myocardial infarction and cardiac arrest. Front Cardiovasc Med. 9(1051978)2022.PubMed/NCBI View Article : Google Scholar

5 

Eltzschig HK and Eckle T: Ischemia and reperfusion-from mechanism to translation. Nat Med. 17:1391–1401. 2011.PubMed/NCBI View Article : Google Scholar

6 

Khan SU, Rahman H, Arshad A, Khan MU, Lekkala M, Yang TJ, Mishra A and Kaluski E: Percutaneous coronary intervention versus surgery in left main stenosis-a meta-analysis and systematic review of randomised controlled trials. Heart Lung Circ. 27:138–146. 2018.PubMed/NCBI View Article : Google Scholar

7 

Heusch G: Cardioprotection: Chances and challenges of its translation to the clinic. Lancet. 381:166–175. 2013.PubMed/NCBI View Article : Google Scholar

8 

Lv B, Zhou J, He S, Zheng Y, Yang W, Liu S, Liu C, Wang B, Li D and Lin J: Induction of myocardial infarction and myocardial ischemia-reperfusion injury in mice. J Vis Exp, 2022.

9 

Scarabelli T, Stephanou A, Rayment N, Pasini E, Comini L, Curello S, Ferrari R, Knight R and Latchman D: Apoptosis of endothelial cells precedes myocyte cell apoptosis in ischemia/reperfusion injury. Circulation. 104:253–256. 2001.PubMed/NCBI View Article : Google Scholar

10 

Chen X, Li X, Zhang W, He J, Xu B, Lei B, Wang Z, Cates C, Rousselle T and Li J: Activation of AMPK inhibits inflammatory response during hypoxia and reoxygenation through modulating JNK-mediated NF-κB pathway. Metabolism. 83:256–270. 2018.PubMed/NCBI View Article : Google Scholar

11 

Neri M, Fineschi V, Di Paolo M, Pomara C, Riezzo I, Turillazzi E and Cerretani D: Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction. Curr Vasc Pharmacol. 13:26–36. 2015.PubMed/NCBI View Article : Google Scholar

12 

Arslan F, Keogh B, McGuirk P and Parker AE: TLR2 and TLR4 in ischemia reperfusion injury. Mediators Inflamm. 2010(704202)2010.PubMed/NCBI View Article : Google Scholar

13 

Ebrahimi H, Badalzadeh R, Mohammadi M and Yousefi B: Diosgenin attenuates inflammatory response induced by myocardial reperfusion injury: Role of mitochondrial ATP-sensitive potassium channels. J Physiol Biochem. 70:425–432. 2014.PubMed/NCBI View Article : Google Scholar

14 

Civril F, Deimling T, de Oliveira Mann CC, Ablasser A, Moldt M, Witte G, Witte G, Hornung V and Hopfner KP: Structural mechanism of cytosolic DNA sensing by cGAS. Nature. 498:332–337. 2013.PubMed/NCBI View Article : Google Scholar

15 

Gulen MF, Koch U, Haag SM, Schuler F, Apetoh L, Villunger A, Radtke F and Ablasser A: Signalling strength determines proapoptotic functions of STING. Nat Commun. 8(427)2017.PubMed/NCBI View Article : Google Scholar

16 

Heidegger S, Haas T and Poeck H: Cutting edge in IFN regulation: Inflammatory caspases cleave cGAS. Immunity. 46:333–335. 2017.PubMed/NCBI View Article : Google Scholar

17 

Liao Y, Cheng J, Kong X, Li S, Li X, Zhang M, Zhang H, Yang T, Dong Y, Li J, et al: HDAC3 inhibition ameliorates ischemia/reperfusion-induced brain injury by regulating the microglial cGAS-STING pathway. Theranostics. 10:9644–9662. 2020.PubMed/NCBI View Article : Google Scholar

18 

Shi X, Chen G and Liu X, Qiu Y, Yang S, Zhang Y, Fang X, Zhang C and Liu X: Scutellarein inhibits cancer cell metastasis in vitro and attenuates the development of fibrosarcoma in vivo. Int J Mol Med. 35:31–38. 2015.PubMed/NCBI View Article : Google Scholar

19 

Hong H and Liu GQ: Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sci. 74:2959–2973. 2004.PubMed/NCBI View Article : Google Scholar

20 

Yang N, Zhao Y, Wang Z, Liu Y and Zhang Y: Scutellarin suppresses growth and causes apoptosis of human colorectal cancer cells by regulating the p53 pathway. Mol Med Rep. 15:929–935. 2017.PubMed/NCBI View Article : Google Scholar

21 

Guo H, Hu LM, Wang SX, Wang YL, Shi F, Li H, Liu Y, Kang LY and Gao XM: Neuroprotective effects of scutellarin against hypoxic-ischemic-induced cerebral injury via augmentation of antioxidant defense capacity. Chin J Physiol. 54:399–405. 2011.PubMed/NCBI View Article : Google Scholar

22 

Zhang HF, Hu XM, Wang LX, Xu SQ and Zeng FD: Protective effects of scutellarin against cerebral ischemia in rats: Evidence for inhibition of the apoptosis-inducing factor pathway. Planta Med. 75:121–126. 2009.PubMed/NCBI View Article : Google Scholar

23 

Wang Z, Yu J, Wu J, Qi F, Wang H, Wang Z and Xu Z: Scutellarin protects cardiomyocyte ischemia-reperfusion injury by reducing apoptosis and oxidative stress. Life Sci. 157:200–207. 2016.PubMed/NCBI View Article : Google Scholar

24 

Xu LJ, Chen RC, Ma XY, Zhu Y, Sun GB and Sun XB: Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation. Phytomedicine. 68(153169)2020.PubMed/NCBI View Article : Google Scholar

25 

Hu XM, Zhou MM, Hu XM and Zeng FD: Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion. Acta Pharmacol Sin. 26:1454–1459. 2005.PubMed/NCBI View Article : Google Scholar

26 

Gao J, Chen G, He H, Liu C, Xiong X, Li J and Wang J: Therapeutic effects of breviscapine in cardiovascular diseases: A review. Front Pharmacol. 8(289)2017.PubMed/NCBI View Article : Google Scholar

27 

Li Y, Lu Y, Hu J, Gong Z, Yang W, Wang A, Zheng J, Liu T, Chen T, Hu J, et al: Pharmacokinetic comparison of scutellarin and paeoniflorin in sham-operated and middle cerebral artery occlusion ischemia and reperfusion injury rats after intravenous administration of Xin-Shao formula. Molecules. 21(1191)2016.PubMed/NCBI View Article : Google Scholar

28 

Wu H and Jia L: Scutellarin attenuates hypoxia/reoxygenation injury in hepatocytes by inhibiting apoptosis and oxidative stress through regulating Keap1/Nrf2/ARE signaling. Biosci Rep. 39(BSR20192501)2019.PubMed/NCBI View Article : Google Scholar

29 

Lin LL, Liu AJ, Liu JG, Yu XH, Qin LP and Su DF: Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats. J Cardiovasc Pharmacol. 50:327–332. 2007.PubMed/NCBI View Article : Google Scholar

30 

Deng F, Zhao BC, Yang X, Lin ZB, Sun QS, Wang YF, Yan ZZ, Liu WF, Li C, Hu JJ and Liu KX: The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis. Gut Microbes. 13:1–21. 2021.PubMed/NCBI View Article : Google Scholar

31 

Huang KY, Que JQ, Hu ZS, Yu YW, Zhou YY, Wang L, Xue YJ, Ji KT and Zhang XM: Metformin suppresses inflammation and apoptosis of myocardiocytes by inhibiting autophagy in a model of ischemia-reperfusion injury. Int J Biol Sci. 16:2559–2579. 2020.PubMed/NCBI View Article : Google Scholar

32 

Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456–1462. 1995.PubMed/NCBI View Article : Google Scholar

33 

Gross A, McDonnell JM and Korsmeyer SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1899–1911. 1999.PubMed/NCBI View Article : Google Scholar

34 

Youle RJ and Strasser A: The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Bio. 9:47–59. 2008.PubMed/NCBI View Article : Google Scholar

35 

Vaux DL, Cory S and Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 335:440–442. 1988.PubMed/NCBI View Article : Google Scholar

36 

Lee R, Kim DW, Lee WY and Park HJ: Zearalenone induces apoptosis and autophagy in a spermatogonia cell line. Toxins (Basel). 14(148)2022.PubMed/NCBI View Article : Google Scholar

37 

Siddiqui WA, Ahad A and Ahsan H: The mystery of BCL2 family: Bcl-2 proteins and apoptosis: An update. Arch Toxicol. 89:289–317. 2015.PubMed/NCBI View Article : Google Scholar

38 

Liu LS, Bai XQ, Gao Y, Wu Q, Ren Z, Li Q, Pan LH, He NY, Peng J and Tang ZH: PCSK9 promotes oxLDL-induced PC12 cell apoptosis through the Bcl-2/Bax-caspase 9/3 signaling pathway. J Alzheimers Dis. 57:723–734. 2017.PubMed/NCBI View Article : Google Scholar

39 

Yao L, Chen H, Wu Q and Xie K: Hydrogen-rich saline alleviates inflammation and apoptosis in myocardial I/R injury via PINK-mediated autophagy. Int J Mol Med. 44:1048–1062. 2019.PubMed/NCBI View Article : Google Scholar

40 

Wu J, Sun L, Chen X, Du F, Shi H, Chen C and Chen ZJ: Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science. 339:826–830. 2013.PubMed/NCBI View Article : Google Scholar

41 

Ishikawa H and Barber GN: STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature. 455:674. 2008.PubMed/NCBI View Article : Google Scholar

42 

Ma R, Ortiz Serrano TP, Davis J, Prigge AD and Ridge KM: The cGAS-STING pathway: The role of self-DNA sensing in inflammatory lung disease. FASEB J. 34:13156–13170. 2020.PubMed/NCBI View Article : Google Scholar

43 

Hao F: An overview of the crosstalk between YAP and cGAS-STING signaling in non-small cell lung cancer: It takes two to tango. Clin Transl Oncol. 24:1661–1672. 2022.PubMed/NCBI View Article : Google Scholar

44 

Xu D, Tian Y, Xia Q and Ke B: The cGAS-STING pathway: Novel perspectives in liver diseases. Front Immunol. 12(682736)2021.PubMed/NCBI View Article : Google Scholar

45 

Wan DS, Jiang W and Hao JW: Research advances in how the cGAS-STING pathway controls the cellular inflammatory response. Front Immunol. 11(615)2020.PubMed/NCBI View Article : Google Scholar

46 

Cao DJ, Schiattarella GG, Villalobos E, Jiang N, May HI, Li T, Chen ZJ, Gillette TG and Hill JA: Cytosolic DNA sensing promotes macrophage transformation and governs myocardial ischemic injury. Circulation. 137:2613–2634. 2018.PubMed/NCBI View Article : Google Scholar

47 

King KR, Aguirre AD, Ye YX, Sun Y, Roh JD, Ng RP Jr, Kohler RH, Arlauckas SP, Iwamoto Y, Savol A, et al: IRF3 and type I interferons fuel a fatal response to myocardial infarction. Nat Med. 23:1481–1487. 2017.PubMed/NCBI View Article : Google Scholar

48 

Chen HL, Jia WJ, Li HE, Han H, Li F, Zhang XLN, Li JJ, Yuan Y and Wu CY: Scutellarin exerts anti-inflammatory effects in activated microglia/brain macrophage in cerebral ischemia and in activated BV-2 microglia through regulation of MAPKs signaling pathway. Neuromolecular Med. 22:264–277. 2020.PubMed/NCBI View Article : Google Scholar

49 

Yuan Y, Zha H, Rangarajan P, Ling EA and Wu C: Anti-inflammatory effects of edaravone and scutellarin in activated microglia in experimentally induced ischemia injury in rats and in BV-2 microglia. BMC Neurosci. 15(125)2014.PubMed/NCBI View Article : Google Scholar

50 

Deng M, Sun J, Peng L, Huang Y, Jiang W, Wu S, Zhou L, Chung S and Cheng X: Scutellarin acts on the AR-NOX axis to remediate oxidative stress injury in a mouse model of cerebral ischemia/reperfusion injury. Phytomedicine. 103(154214)2022.PubMed/NCBI View Article : Google Scholar

51 

Zhang Y, Zhang Z, Wang J, Zhang X, Zhao J, Bai N, Vijayalakshmi A and Huo Q: Scutellarin alleviates cerebral ischemia/reperfusion by suppressing oxidative stress and inflammatory responses via MAPK/NF-κB pathways in rats. Environ Toxicol. 37:2889–2896. 2022.PubMed/NCBI View Article : Google Scholar

52 

Hwang I, Uchida H, Dai Z, Li F, Sanchez T, Locasale JW, Cantley LC, Zheng H and Paik J: Cellular stress signaling activates type-I IFN response through FOXO3-regulated lamin posttranslational modification. Nat Commun. 12(640)2021.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Li J, Song Z and Hou X: Scutellarin ameliorates ischemia/reperfusion injury‑induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS‑STING pathway. Exp Ther Med 25: 155, 2023.
APA
Li, J., Song, Z., & Hou, X. (2023). Scutellarin ameliorates ischemia/reperfusion injury‑induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS‑STING pathway. Experimental and Therapeutic Medicine, 25, 155. https://doi.org/10.3892/etm.2023.11854
MLA
Li, J., Song, Z., Hou, X."Scutellarin ameliorates ischemia/reperfusion injury‑induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS‑STING pathway". Experimental and Therapeutic Medicine 25.4 (2023): 155.
Chicago
Li, J., Song, Z., Hou, X."Scutellarin ameliorates ischemia/reperfusion injury‑induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS‑STING pathway". Experimental and Therapeutic Medicine 25, no. 4 (2023): 155. https://doi.org/10.3892/etm.2023.11854
Copy and paste a formatted citation
x
Spandidos Publications style
Li J, Song Z and Hou X: Scutellarin ameliorates ischemia/reperfusion injury‑induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS‑STING pathway. Exp Ther Med 25: 155, 2023.
APA
Li, J., Song, Z., & Hou, X. (2023). Scutellarin ameliorates ischemia/reperfusion injury‑induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS‑STING pathway. Experimental and Therapeutic Medicine, 25, 155. https://doi.org/10.3892/etm.2023.11854
MLA
Li, J., Song, Z., Hou, X."Scutellarin ameliorates ischemia/reperfusion injury‑induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS‑STING pathway". Experimental and Therapeutic Medicine 25.4 (2023): 155.
Chicago
Li, J., Song, Z., Hou, X."Scutellarin ameliorates ischemia/reperfusion injury‑induced cardiomyocyte apoptosis and cardiac dysfunction via inhibition of the cGAS‑STING pathway". Experimental and Therapeutic Medicine 25, no. 4 (2023): 155. https://doi.org/10.3892/etm.2023.11854
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team